Cargando…
Dysregulated iron metabolism in polycythemia vera: etiology and consequences
Polycythemia vera (PV) is a chronic myeloproliferative neoplasm. Virtually all PV patients are iron deficient at presentation and/or during the course of their disease. The co-existence of iron deficiency and polycythemia presents a physiological disconnect. Hepcidin, the master regulator of iron me...
Autores principales: | Ginzburg, Yelena Z., Feola, Maria, Zimran, Eran, Varkonyi, Judit, Ganz, Tomas, Hoffman, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170398/ https://www.ncbi.nlm.nih.gov/pubmed/30042411 http://dx.doi.org/10.1038/s41375-018-0207-9 |
Ejemplares similares
-
P1016: RUSFERTIDE (PTG-300) IMPROVES POLYCYTHEMIA VERA (PV) RELATED SYMPTOMS IN PV PATIENTS
por: Kuykendall, Andrew, et al.
Publicado: (2023) -
Recent advances in prognostication and treatment of polycythemia vera
por: Marcellino, Bridget K, et al.
Publicado: (2021) -
Tmprss6-ASO as a tool for the treatment of Polycythemia Vera mice
por: Casu, Carla, et al.
Publicado: (2021) -
Masked polycythemia vera due to iron deficiency anemia
por: Hotta, Koma, et al.
Publicado: (2023) -
Iron homeostasis governs erythroid phenotype in polycythemia vera
por: Bennett, Cavan, et al.
Publicado: (2023)